ARK reports 12.29% Beam Therapeutics (BEAM) ownership stake

Rhea-AI Filing Summary

ARK Investment Management LLC and Catherine D. Wood report a significant passive stake in Beam Therapeutics Inc. common stock. As of 12/31/2025, they beneficially owned 12,467,189 shares, representing 12.29% of Beam’s common stock.

ARK has sole voting power over 11,797,335 shares and shared voting power over 232,371 shares, with sole dispositive power over all 12,467,189 shares. Catherine Wood shares voting power over 12,029,706 shares and shares dispositive power over 12,467,189 shares. They certify the position is held in the ordinary course of business without the purpose of changing or influencing control, and note that ARK Innovation ETF is the only ARK client with an interest above 5%.

Insights

Equity Ownership Analyst

ARK discloses a 12.29% passive stake in Beam Therapeutics.

ARK Investment Management LLC and Catherine D. Wood report beneficial ownership of 12,467,189 Beam Therapeutics shares, or 12.29% of the company’s common stock as of 12/31/2025. This is a substantial institutional holding in a single issuer.

ARK holds sole voting power over 11,797,335 shares and sole dispositive power over the full 12,467,189-share position. Catherine Wood is reported with shared voting power over 12,029,706 shares and shared dispositive power over 12,467,189 shares, reflecting her role at ARK.

The filers certify the position was acquired and is held in the ordinary course of business, without the purpose or effect of changing or influencing control. They also state that no ARK client other than ARK Innovation ETF has an interest above 5% of this class, indicating concentration primarily in that fund.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 6)

Beam Therapeutics Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

07373V105

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 07373V105

1

Names of Reporting Persons

ARK Investment Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 11,797,335.00
6	Shared Voting Power 232,371.00
7	Sole Dispositive Power 12,467,189.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

12,467,189.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

12.29 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 07373V105

1

Names of Reporting Persons

Catherine D. Wood

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 12,029,706.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 12,467,189.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

12,467,189.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

12.29 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Beam Therapeutics Inc.
(b)	Address of issuer's principal executive offices: 238 Main Street, Cambridge, MA, 02142
Item 2.
(a)	Name of person filing: (i) ARK Investment Management LLC ("ARK") (ii) Catherine D. Wood
(b)	Address or principal business office or, if none, residence: ARK and Catherine D. Wood: 200 Central Avenue, St. Petersburg, FL 33701
(c)	Citizenship: (i) ARK: Delaware (ii) Catherine D. Wood: United States
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 07373V105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: ARK and Catherine D. Wood: 12,467,189
(b)	Percent of class: ARK and Catherine D. Wood: 12.29
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: (i) ARK: 11,797,335 (ii) Catherine D. Wood: 0
	(ii) Shared power to vote or to direct the vote: (i) ARK: 232,371 (ii) Catherine D. Wood: 12,029,706
	(iii) Sole power to dispose or to direct the disposition of: (i) ARK: 12,467,189 (ii) Catherine D. Wood: 0
	(iv) Shared power to dispose or to direct the disposition of: (i) ARK: 0 (ii) Catherine D. Wood: 12,467,189
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. No client of ARK Investment Management LLC currently has an interest in the securities reported herein in excess of 5 percent except ARK Innovation ETF, a series of a Delaware statutory trust.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

ARK Investment Management LLC

Signature:	/s/ Kellen Carter
Name/Title:	Kellen Carter, Chief Compliance Officer
Date:	02/03/2026

Catherine D. Wood

Signature:	/s/ Catherine D. Wood
Name/Title:	Catherine D. Wood, Chief Executive Officer, Chief Investment Officer
Date:	02/03/2026

FAQ

What percentage of Beam Therapeutics (BEAM) does ARK Investment Management report owning?

ARK Investment Management LLC and Catherine D. Wood report beneficial ownership of 12.29% of Beam Therapeutics’ common stock. This corresponds to 12,467,189 shares as of 12/31/2025, indicating a sizable institutional position in the company’s equity.

How many Beam Therapeutics shares does ARK Investment Management beneficially own?

ARK Investment Management LLC and Catherine D. Wood beneficially own 12,467,189 shares of Beam Therapeutics common stock. This stake, reported as of 12/31/2025, represents 12.29% of the outstanding class, making ARK a major shareholder in BEAM.

Is ARK’s Beam Therapeutics (BEAM) stake reported as a passive investment?

Yes. The filers certify the Beam Therapeutics shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control, consistent with a passive Schedule 13G filing status for this 12.29% stake.

What voting and dispositive power does ARK have over its Beam Therapeutics shares?

ARK reports sole voting power over 11,797,335 shares and shared voting power over 232,371 shares of Beam Therapeutics. It also has sole dispositive power over all 12,467,189 shares, indicating primary control over decisions to sell or hold the position.

How is Catherine D. Wood’s ownership in Beam Therapeutics (BEAM) characterized?

Catherine D. Wood is reported with shared voting power over 12,029,706 Beam Therapeutics shares and shared dispositive power over 12,467,189 shares. She has no sole voting or dispositive power, reflecting her role in overseeing ARK’s investment management activities.

Which ARK client holds more than 5% of Beam Therapeutics according to this filing?

The filing states that no ARK Investment Management LLC client has an interest above 5% in Beam Therapeutics, except ARK Innovation ETF, a series of a Delaware statutory trust. This identifies ARK Innovation ETF as the primary ARK client with a concentrated BEAM position.